Skip to main content
12 December 2024
Last updated:
Monday 9 December 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Immunotherapies show positive data at ESMO
Read more
Triple Negative Breast Cancer: A subtractive approach to treatment
Read more
Taming food-induced immune disorders
Read more
The US continues to lead in oncology approvals
Read more
Genmab looks ahead to next phase of growth
Read more
Long-term strategies for immuno-oncology
Read more
Novel immunotherapy arises from collaboration
Read more
Medigene on a new course
Read more
Using the accelerator and brake to treat cancer
Read more
How Pharma is targeting checkpoint inhibitors
Read more
Pagination
Current page
1
Page
2
Page
3
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form